| |
| Issue |
Title |
| |
| Vol 25, No 2 (2025) |
Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy |
Abstract
PDF (Rus)
|
|
D. S. Kopein, G. N. Poroshin, R. A. Khamitov |
| |
| Vol 25, No 2 (2025) |
Human hepatitis B immunoglobulins: Standardisation issues |
Abstract
PDF (Rus)
|
|
E. A. Konovalova, E. N. Kalinina, E. S. Kormshchikova, E. V. Rosina, S. E. Ziganshina, K. A. Vorobiev, I. V. Paramonov |
| |
| Vol 25, No 2 (2025) |
Application of 3Rs principles to assess the quality of DPT vaccine: Advantages and disadvantages |
Abstract
PDF (Rus)
|
|
E. I. Komarovskaya, O. V. Proskurina |
| |
| Vol 25, No 2 (2025) |
Lyophilization of microorganisms standardized by the number of viable cells in low concentration: Development of a drying mode |
Abstract
PDF (Rus)
|
|
A. A. Voropaev, Yu. I. Krysanova, O. V. Fadeikina, R. M. Valyukhova, D. S. Davydov |
| |
| Vol 25, No 2 (2025) |
Certification of a pharmacopoeial reference standard for potency testing of adsorbed tetanus toxoid in guinea pigs |
Abstract
PDF (Rus)
|
|
E. I. Komarovskaya, O. V. Fadeikina, K. A. Lysko, R. A. Volkova, O. G. Kornilova |
| |
| Vol 25, No 2 (2025) |
Quality control programmes for induced pluripotent stem cell-derived medicinal products |
Abstract
PDF (Rus)
|
|
E. V. Melnikova, O. A. Rachinskaya, I. S. Semenova, V. A. Merkulov |
| |
| 1 - 6 of 6 Items |
|
